China National Accord Medicines Corporation Ltd. (000028.SZ)
CNY 29.96
(-0.5%)
CNY 29.96
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 75.47 Billion | 73.44 Billion | 68.35 Billion | 59.64 Billion | 52.04 Billion | 43.12 Billion |
| Cost of Revenue | 66.47 Billion | 64.51 Billion | 60.33 Billion | 52.59 Billion | 46.29 Billion | 38.02 Billion |
| Gross Profit | 9 Billion | 8.92 Billion | 8.01 Billion | 7.05 Billion | 5.75 Billion | 5.09 Billion |
| Operating Expenses | 6.58 Billion | 6.51 Billion | 5.86 Billion | 5.03 Billion | 3.99 Billion | 3.63 Billion |
| Selling, General and Administrative Expenses | 4.98 Billion | 5.47 Billion | 4.93 Billion | 4.14 Billion | 3.22 Billion | 2.91 Billion |
| Research and Development Expenses | 26.82 Million | 9.06 Million | 7.74 Million | - | - | - |
| Other Expenses | 6.5 Million | 1.03 Billion | 928.26 Million | 891.45 Million | 763.07 Million | 7.95 Million |
| Cost and Expenses | 73.07 Billion | 71.03 Billion | 66.2 Billion | 57.62 Billion | 50.28 Billion | 41.66 Billion |
| Operating Income | 2.34 Billion | 2.3 Billion | 1.95 Billion | 2.16 Billion | 1.83 Billion | 1.67 Billion |
| Interest Expense | 285.04 Million | 261.9 Million | 288.03 Million | 258.18 Million | 271.71 Million | 195.25 Million |
| Income Tax Expense | 514.73 Million | 539.33 Million | 447.21 Million | 435.94 Million | 372.43 Million | 330.49 Million |
| Earnings before Tax | 2.15 Billion | 2.31 Billion | 1.97 Billion | 2.15 Billion | 1.85 Billion | 1.67 Billion |
| Net Income | 1.59 Billion | 1.48 Billion | 1.33 Billion | 1.4 Billion | 1.27 Billion | 1.21 Billion |
| Earnings Per Share Basic | 2.87 | 2.67 | 2.40 | 2.52 | 2.28 | 2.18 |
| Earnings Per Share Diluted | 2.87 | 2.67 | 2.40 | 2.52 | 2.28 | 2.18 |
| Weighted Average Shares Outstanding | 557.23 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 556.56 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.17 Million |
| Gross Margin | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
| EBIT Margin | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| EBITDA | 4.03 Billion | 3.76 Billion | 3.4 Billion | 3.29 Billion | 2.75 Billion | 1.8 Billion |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 18.68 Billion | 18.69 Billion | 19.04 Billion | 18.84 Billion | 75.28 Billion | 18.19 Billion |
| Cost of Revenue | 16.68 Billion | 16.62 Billion | 17.01 Billion | 16.77 Billion | 67.95 Billion | 16.11 Billion |
| Gross Profit | 1.99 Billion | 2.06 Billion | 2.02 Billion | 2.06 Billion | 7.33 Billion | 2.08 Billion |
| Operating Expenses | 1.58 Billion | 18.29 Billion | 1.56 Billion | 1.38 Billion | 5 Billion | 1.55 Billion |
| Selling, General and Administrative Expenses | 3.36 Billion | 1.21 Billion | 1.55 Billion | 1.37 Billion | - | 1.96 Billion |
| Research and Development Expenses | 6.27 Million | 6.7 Million | 6.26 Million | 8.47 Million | - | 5.92 Million |
| Other Expenses | -1.78 Billion | -18.29 Billion | -1.81 Million | -8.92 Million | 6.5 Million | -16.44 Million |
| Cost and Expenses | 18.26 Billion | 18.29 Billion | 18.58 Billion | 18.16 Billion | 72.95 Billion | 17.66 Billion |
| Operating Income | 395.58 Million | 404.85 Million | 464.93 Million | 677.54 Million | 2.33 Billion | 527.8 Million |
| Interest Expense | 67.46 Million | 76.33 Million | 54.74 Million | 64.86 Million | 248.38 Million | 75.26 Million |
| Income Tax Expense | 72.87 Million | 110.35 Million | 104.12 Million | 144.48 Million | 514.73 Million | 108 Million |
| Earnings before Tax | 398.49 Million | 407.71 Million | 439.91 Million | 569.77 Million | 2.15 Billion | 528.79 Million |
| Net Income | 322.05 Million | 354.71 Million | 388.77 Million | 409.59 Million | 1.59 Billion | 359.41 Million |
| Earnings Per Share Basic | 0.58 | 0.64 | 0.70 | 0.74 | - | 0.65 |
| Earnings Per Share Diluted | 0.58 | 0.64 | 0.70 | 0.74 | - | 0.65 |
| Weighted Average Shares Outstanding | 555.26 Million | 463.54 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 555.26 Million | 463.54 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.56 Million |
| Gross Margin | 0.11 | 0.11 | 0.11 | 0.11 | 0.10 | 0.11 |
| EBIT Margin | 0.02 | 0.03 | 0.03 | 0.06 | - | 0.03 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 465.96 Million | 494.72 Million | 649.59 Million | 1.08 Billion | - | 621.81 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
FG
0H8T
STEM
GNFC
AOMFF
5714